Skip to content

Effect of rapid carbapenemases detection-guided antibiotic therapy on clinical response in patients with intra-abdominal infections

Effect of rapid carbapenemases detection-guided antibiotic therapy on clinical response in patients with intra-abdominal infections

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076159
Enrollment
Unknown
Registered
2023-09-26
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra-abdominal infection

Interventions

GICA group:Additional colloidal gold immunochromatographic assay (GICA) performed on the first suspected CRE positive blood culture based on conventional microbial testing
Conventional group:Conventional microbial testing

Sponsors

Jinling Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged over 18; 2. Diagnosed as intra-abdominal infection; 3. APACHE II score = 10 or combined with sepsis (SOFA score = 2); 4. Gram negative bacteria were found in blood cultures; 5. Able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Death within 48 hours of admission; 2. The bacterial cultures are negative; 3. Severe liver or kidney dysfunction (single liver or kidney SOFA score =3 points) 4. Pregnant or lactating women; 5. Participating other clinical trials in the previous 4 weeks;

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
Hospital stay;ICU stay;Microbial clearance rate;

Countries

China

Contacts

Public ContactRen Jianan

Jinling Hospital

jiananr@nju.edu.cn+86 188 5165 0168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026